Past

We were excited to attend the American College of Toxicology (ACT) 2024 annual meeting in Austin, Texas! ACT is a global community of professional scientists representing the pharmaceutical and biotech industries, regulatory agencies, contract research organizations, academia, and consulting firms. The 45th Annual Meeting  included a wide-ranging scientific program and educational courses, with distinguished plenary

We were excited to attend the Extractables & Leachables Europe 2024 conference, held in Vienna, Austria. Supported by ELSIE, this conference was dedicated to discussing extractables and leachables examination as the importance of this area continues to grow. Given the current scrutiny paid by governing bodies including the FDA and MHRA, understanding the best practice

We were thrilled to host a Lhasa Limited Symposium in Shanghai, China, alongside CloudScientific. On 17th October 2024, we brought together professionals from industry to address critical topics on on impurity assessment and control in drug development and manufacturing. The event offered valuable insights from experts on ICH M7 assessment, process and degradation impurities, and

We were thrilled to host another Lhasa Limited Symposium in Seoul, South Korea, alongside BITEK CHEMS. On 15th October 2024, we brought together professionals from industry and regulatory bodies to address critical topics in chemical safety, with a particular focus on the ongoing challenges of nitrosamine risk assessment. The event offered valuable insights from experts

We were delighted to attend the 5th COLAMA meeting in the city of Bogotá, Colombia! For more than 20 years COLAMA has brought together the main exponents of alternatives to animals testing, providing a space for knowledge sharing between industry experts, and the research advances achieved in the LATAM region. Lhasa held an industry hosted

The Lhasa Limited Japan symposium returned to Tokyo in September 2024. On 12th September, we brought together professionals from industry and regulatory bodies to address critical topics in chemical safety, with a particular focus on the ongoing challenges of nitrosamine risk assessment. The event offered valuable insights from experts on ICH M7 assessment, nitrosamine risk